Manufaktura Urody Sp. z o.o.
- Address
- Ul. Naleczowska 33/u7, 02-922 Warsaw, Poland
Atopic Dermatitis Research
The site is advancing treatments for Atopic dermatitis, a key condition within the Skin and Connective Tissue Diseases therapeutic area, by testing new biologic agents aimed at reducing skin inflammation and improving patient quality of life.
- Evaluation of novel monoclonal antibodies for disease control
- Assessment of severity reduction using standardized scoring systems
- Safety monitoring in diverse adult populations
Ongoing studies seek to demonstrate that emerging therapies can provide faster and more sustained relief for individuals living with moderate‑to‑severe disease.
Hidradenitis Suppurativa Research
At Manufaktura Urody Sp. z o.o., investigators are focusing on Hidradenitis Suppurativa, an inflammatory disorder classified under Immune System Diseases, to explore treatments that lessen lesion formation and improve long‑term outcomes.
- Testing targeted therapies that reduce abscess and nodule counts
- Comparative effectiveness versus placebo controls
- Comprehensive safety profiling in both genders
The goal is to identify options that can modify disease progression and provide meaningful symptom relief for patients with moderate‑to‑severe presentations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Bluefin Biomedicine Inc.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Bluefin Biomedicine Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Manufaktura Urody Sp. z o.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Moderate to Severe Hidradenitis Suppurativa | Bluefin Biomedicine Inc. | Phase II | Recruiting | Apr 2026 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| HUMANISED IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST THYMIC STROMAL LYMPHOPOIETIN | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.